Published in Maturitas on January 08, 2009
Osteoporosis: now and the future. Lancet (2011) 5.81
Oral bisphosphonates and risk of cancer of oesophagus, stomach, and colorectum: case-control analysis within a UK primary care cohort. BMJ (2010) 4.92
European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int (2012) 4.88
Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. Osteoporos Int (2010) 3.36
Interpretation and use of FRAX in clinical practice. Osteoporos Int (2011) 2.43
Clarifying WHO's position on the FRAX® tool for fracture prediction. Bull World Health Organ (2016) 2.01
Obesity is not protective against fracture in postmenopausal women: GLOW. Am J Med (2011) 1.95
Models of care for the secondary prevention of osteoporotic fractures: a systematic review and meta-analysis. Osteoporos Int (2012) 1.80
UK clinical guideline for the prevention and treatment of osteoporosis. Arch Osteoporos (2017) 1.40
Filtering FRAX. Osteoporos Int (2010) 1.40
A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis. Osteoporos Int (2012) 1.36
Osteoporosis, frailty and fracture: implications for case finding and therapy. Nat Rev Rheumatol (2012) 1.28
Predicting risk of osteoporotic and hip fracture in the United Kingdom: prospective independent and external validation of QFractureScores. BMJ (2011) 1.25
Osteoporosis in young adults: pathophysiology, diagnosis, and management. Osteoporos Int (2012) 1.25
Prevalence and related risk factors of osteoporosis in peri- and postmenopausal Indian women. J Midlife Health (2011) 1.20
Management of glucocorticoid-induced osteoporosis. Nat Rev Rheumatol (2010) 1.16
Update in male osteoporosis. J Clin Endocrinol Metab (2010) 1.15
Overweight/obesity and underweight are both risk factors for osteoporotic fractures at different sites in Japanese postmenopausal women. Osteoporos Int (2012) 1.13
A systematic review of the effectiveness of interventions to improve post-fracture investigation and management of patients at risk of osteoporosis. Implement Sci (2010) 1.09
Calibration of FRAX ® 3.1 to the Dutch population with data on the epidemiology of hip fractures. Osteoporos Int (2011) 1.02
Assessment of individual fracture risk: FRAX and beyond. Curr Osteoporos Rep (2010) 1.01
Guidance for the adjustment of FRAX according to the dose of glucocorticoids. Osteoporos Int (2011) 1.00
Comparison between various fracture risk assessment tools. Osteoporos Int (2014) 1.00
A reappraisal of generic bisphosphonates in osteoporosis. Osteoporos Int (2011) 0.98
Advances in bone imaging for osteoporosis. Nat Rev Endocrinol (2013) 0.97
Differing perceptions of intervention thresholds for fracture risk: a survey of patients and doctors. Osteoporos Int (2011) 0.96
Understanding effects in reviews of implementation interventions using the Theoretical Domains Framework. Implement Sci (2015) 0.95
A systematic review of intervention thresholds based on FRAX : A report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation. Arch Osteoporos (2016) 0.92
Updated fracture incidence rates for the Italian version of FRAX®. Osteoporos Int (2012) 0.92
Risk factors for nonvertebral fracture in obese older women. J Clin Endocrinol Metab (2011) 0.92
Cost-effective intervention thresholds against osteoporotic fractures based on FRAX® in Switzerland. Osteoporos Int (2012) 0.90
Prediction of absolute risk of fragility fracture at 10 years in a Spanish population: validation of the WHO FRAX ™ tool in Spain. BMC Musculoskelet Disord (2011) 0.89
Percentage of the population at high risk of osteoporotic fracture in South Korea: analysis of the 2010 Fifth Korean National Health and Nutrition Examination survey data. Osteoporos Int (2013) 0.89
A pragmatic randomised controlled trial of the effectiveness and cost-effectiveness of screening older women for the prevention of fractures: rationale, design and methods for the SCOOP study. Osteoporos Int (2012) 0.88
Causes, consequences, and treatment of osteoporosis in men. Drug Des Devel Ther (2013) 0.87
Complications of long-term therapy for ANCA-associated systemic vasculitis. Nat Rev Nephrol (2012) 0.86
Burden of high fracture probability worldwide: secular increases 2010-2040. Osteoporos Int (2015) 0.85
Validation of FRC, a fracture risk assessment tool, in a cohort of older men: the Osteoporotic Fractures in Men (MrOS) Study. J Clin Densitom (2012) 0.85
Mild morphometric vertebral fractures predict vertebral fractures but not non-vertebral fractures. Osteoporos Int (2013) 0.85
MicroRNA-146a regulates human foetal femur derived skeletal stem cell differentiation by down-regulating SMAD2 and SMAD3. PLoS One (2014) 0.84
Exercise prescription after fragility fracture in older adults: a scoping review. Osteoporos Int (2010) 0.84
FRAX-based assessment and intervention thresholds--an exploration of thresholds in women aged 50 years and older in the UK. Osteoporos Int (2015) 0.82
A comparison of case-finding strategies in the UK for the management of hip fractures. Osteoporos Int (2012) 0.81
Prevalence of risk factors for fractures and use of DXA scanning in Danish women. A regional population-based study. Osteoporos Int (2010) 0.81
The distribution of FRAX(®)-based probabilities in women from Japan. J Bone Miner Metab (2012) 0.81
Possible FRAX-based intervention thresholds for a cohort of Chinese postmenopausal women. Osteoporos Int (2013) 0.80
Bone anabolics in osteoporosis: Actuality and perspectives. World J Orthop (2014) 0.80
Association between passive smoking in adulthood and phalangeal bone mineral density: results from the KRAM study--the Danish Health Examination Survey 2007-2008. Osteoporos Int (2010) 0.80
Management of osteoporosis in patients hospitalized for hip fractures. Osteoporos Int (2010) 0.80
The discriminative ability of FRAX, the WHO algorithm, to identify women with prevalent asymptomatic vertebral fractures: a cross-sectional study. BMC Musculoskelet Disord (2014) 0.79
Commentary on guidelines on postmenopausal osteoporosis - Indian Menopause Society. J Midlife Health (2013) 0.78
The effect of weight and weight change on the long-term precision of spine and hip DXA measurements. Osteoporos Int (2010) 0.78
Intervention thresholds for denosumab in the UK using a FRAX®-based cost-effectiveness analysis. Osteoporos Int (2012) 0.78
[Diagnosis of osteoporosis in geriatric patients - possibilities and limitations]. Wien Med Wochenschr (2011) 0.78
ACG Clinical Guideline: Preventive Care in Inflammatory Bowel Disease. Am J Gastroenterol (2017) 0.78
The role of the combination of bone and fall related risk factors on short-term subsequent fracture risk and mortality. BMC Musculoskelet Disord (2013) 0.77
Hip fracture and other predictors of anti-osteoporosis drug use in Norway. Osteoporos Int (2012) 0.77
Association between Serum Cholesterol Level and Bone Mineral Density at Lumbar Spine and Femur Neck in Postmenopausal Korean Women. Korean J Fam Med (2012) 0.77
Trends in oral anti-osteoporosis drug prescription in the United Kingdom between 1990 and 2012: Variation by age, sex, geographic location and ethnicity. Bone (2016) 0.77
A knowledge translation tool improved osteoporosis disease management in primary care: an interrupted time series analysis. Implement Sci (2014) 0.77
FRAX®: prediction of major osteoporotic fractures in women from the general population: the OPUS study. PLoS One (2013) 0.77
Fracture prevention in men. Nat Rev Rheumatol (2009) 0.76
Oral alendronate can suppress bone turnover but not fracture in kidney transplantation recipients with hyperparathyroidism and chronic kidney disease. J Bone Miner Metab (2012) 0.76
Impact of femoral neck and lumbar spine BMD discordances on FRAX probabilities in women: a meta-analysis of international cohorts. Calcif Tissue Int (2014) 0.76
Comparison of the proportion of patients potentially treated with an anti-osteoporotic drug using the current criteria of the Belgian national social security and the new suggested FRAX criteria. Rheumatol Int (2012) 0.75
Novel advances in the treatment of osteoporosis. Br Med Bull (2016) 0.75
Management options of breast cancer related osteoporosis. Clin Cases Miner Bone Metab (2014) 0.75
EFFECTS OF NORMAL AGING ON LOWER EXTREMITY LOADING AND COORDINATION DURING RUNNING IN MALES AND FEMALES. Int J Sports Phys Ther (2015) 0.75
Cost-effective osteoporosis treatment thresholds in Greece. Osteoporos Int (2015) 0.75
Cardiovascular risk factor analysis in patients with a recent clinical fracture at the fracture liaison service. Biomed Res Int (2014) 0.75
Public priorities for osteoporosis and fracture research: results from a general population survey. Arch Osteoporos (2017) 0.75
What Do We Know about Individuals Who Are Assessed as Being at Moderate Risk for Future Fracture in Canada? Health (Irvine Calif) (2015) 0.75
Lower Bone Mineral Density at the Hip and Lumbar Spine in People with Psychosis Versus Controls: a Comprehensive Review and Skeletal Site-Specific Meta-analysis. Curr Osteoporos Rep (2016) 0.75
Systemic lupus erythematosus and fractures. RMD Open (2015) 0.75
Digital X-ray radiogrammetry in the study of osteoporotic fractures: Comparison to dual energy X-ray absorptiometry and FRAX. Bone (2016) 0.75
Improving Osteoporosis Management in Primary Care: An Audit of the Impact of a Community Based Fracture Liaison Nurse. PLoS One (2015) 0.75
Randomised trial assessing the impact of framing of fracture risk and osteoporosis treatment benefits in patients undergoing bone densitometry. BMJ Open (2017) 0.75
A practical approach to osteoporosis management in the geriatric population. Can Geriatr J (2015) 0.75
NICE: Its Influence in Treating Osteoporosis in the UK and beyond. Ther Adv Musculoskelet Dis (2009) 0.75
Identifying and managing patients at high risk for fractures: conclusions from the second Spanish multidisciplinary forum-parathyroid hormone use in osteoporotic patients at high risk for fractures. Drugs R D (2012) 0.75
Risedronate's Role in Reducing Hip Fracture in Postmenopausal Women with Established Osteoporosis. Clin Med Insights Arthritis Musculoskelet Disord (2012) 0.75
The risk of osteoporotic fractures and its associating risk factors according to the FRAX model in the Iranian patients: a follow-up cohort. J Diabetes Metab Disord (2014) 0.75
Prevalence of Bone Mineral Density Abnormalities and Factors Affecting Bone Density in Patients with Chronic Obstructive Pulmonary Disease in a Tertiary Care Hospital in Southern India. J Clin Diagn Res (2016) 0.75
Epidemic of fractures during a period of snow and ice: has anything changed 33 years on? BMJ Open (2016) 0.75
Does regional loss of bone density explain low trauma distal forearm fractures in men (the Mr F study)? Osteoporos Int (2017) 0.75
Olecranon Fractures Have Features of Osteoporotic Fracture. J Bone Metab (2017) 0.75
The FRAX-based Lebanese osteoporosis treatment guidelines: rationale for a hybrid model. Osteoporos Int (2016) 0.75
FRAX- vs. T-score-based intervention thresholds for osteoporosis. Osteoporos Int (2017) 0.75
Access to fracture risk assessment by FRAX and linked National Osteoporosis Guideline Group (NOGG) guidance in the UK-an analysis of anonymous website activity. Osteoporos Int (2016) 0.75
Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res (1987) 24.27
An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int (2006) 11.05
Ancient DNA: do it right or not at all. Science (2000) 7.84
World-wide projections for hip fracture. Osteoporos Int (1997) 6.83
The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int (2007) 6.44
Risk of new vertebral fracture in the year following a fracture. JAMA (2001) 6.17
Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am (2002) 5.95
Epidemiology of fractures in England and Wales. Bone (2001) 5.76
Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi. J Clin Microbiol (1997) 5.64
Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int (2005) 5.54
Elective ventilation of potential organ donors. BMJ (1995) 5.50
European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int (2008) 5.27
Perspective. How many women have osteoporosis? J Bone Miner Res (1992) 4.99
Maternal vitamin D status during pregnancy and childhood bone mass at age 9 years: a longitudinal study. Lancet (2006) 4.95
A meta-analysis of previous fracture and subsequent fracture risk. Bone (2004) 4.92
European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int (2012) 4.88
Radiographic patterns of osteoarthritis of the knee joint in the community: the importance of the patellofemoral joint. Ann Rheum Dis (1992) 4.79
Ferricytochrome c. I. General features of the horse and bonito proteins at 2.8 A resolution. J Biol Chem (1971) 4.75
Use of oral corticosteroids and risk of fractures. J Bone Miner Res (2000) 4.75
Racial disparities in access to renal transplantation--clinically appropriate or due to underuse or overuse? N Engl J Med (2000) 4.67
EULAR recommendations for the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis (2000) 4.37
An estimate of the worldwide prevalence, mortality and disability associated with hip fracture. Osteoporos Int (2004) 4.24
Allostery without conformational change. A plausible model. Eur Biophys J (1984) 3.89
Bone density screening for osteoporosis. Lancet (1990) 3.87
Human parvovirus-associated arthritis: a clinical and laboratory description. Lancet (1985) 3.82
Defining osteoarthritis of the hip for epidemiologic studies. Am J Epidemiol (1990) 3.77
Excess mortality following hip fracture: a systematic epidemiological review. Osteoporos Int (2009) 3.74
Mortality after osteoporotic fractures. Osteoporos Int (2003) 3.68
CED-12/ELMO, a novel member of the CrkII/Dock180/Rac pathway, is required for phagocytosis and cell migration. Cell (2001) 3.67
Cohort profile: the Hertfordshire cohort study. Int J Epidemiol (2005) 3.62
A systematic review of hip fracture incidence and probability of fracture worldwide. Osteoporos Int (2012) 3.62
Intracellular trafficking in Mycobacterium tuberculosis and Mycobacterium avium-infected macrophages. J Immunol (1994) 3.55
Dynamics of Pleistocene population extinctions in Beringian brown bears. Science (2002) 3.53
Bone densitometry in clinical practice. BMJ (1995) 3.48
The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporos Int (2002) 3.45
Case finding for the management of osteoporosis with FRAX--assessment and intervention thresholds for the UK. Osteoporos Int (2008) 3.44
Complete genomic sequence and analysis of the prion protein gene region from three mammalian species. Genome Res (1998) 3.44
Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. Osteoporos Int (2010) 3.36
The prevalence of vertebral deformity in european men and women: the European Vertebral Osteoporosis Study. J Bone Miner Res (1996) 3.25
Determinants of disability in osteoarthritis of the knee. Ann Rheum Dis (1993) 3.16
Fluoride in drinking water and risk of hip fracture in the UK: a case-control study. Lancet (2000) 3.16
Incidence of vertebral fracture in europe: results from the European Prospective Osteoporosis Study (EPOS). J Bone Miner Res (2002) 3.16
Knee pain and disability in the community. Br J Rheumatol (1992) 3.15
Smoking and fracture risk: a meta-analysis. Osteoporos Int (2004) 3.08
Secular trends in the incidence of hip and other osteoporotic fractures. Osteoporos Int (2011) 3.04
Pectin esterification is spatially regulated both within cell walls and between developing tissues of root apices. Planta (1990) 3.03
Thermodynamic fluctuations in protein molecules. Proc Natl Acad Sci U S A (1976) 3.00
GP job satisfaction in 1987, 1990 and 1998: lessons for the future? Fam Pract (2000) 2.99
Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy. Arthritis Rheum (2003) 2.94
Maternal vitamin D status during pregnancy and child outcomes. Eur J Clin Nutr (2007) 2.94
Results of indirect and mixed treatment comparison of fracture efficacy for osteoporosis treatments: a meta-analysis. Osteoporos Int (2012) 2.81
Effect of annual intramuscular vitamin D on fracture risk in elderly men and women--a population-based, randomized, double-blind, placebo-controlled trial. Rheumatology (Oxford) (2007) 2.81
Guidelines for diagnosis and management of osteoporosis. The European Foundation for Osteoporosis and Bone Disease. Osteoporos Int (1997) 2.80
Cytokinin and gibberellin-like activity in the spring sap of trees. Experientia (1968) 2.80
Systemic absorption of progesterone from Progest cream in postmenopausal women. Lancet (1998) 2.78
Effect of tamoxifen on bone mineral density measured by dual-energy x-ray absorptiometry in healthy premenopausal and postmenopausal women. J Clin Oncol (1996) 2.76
Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. Lancet (1991) 2.75
Back pain in Britain: comparison of two prevalence surveys at an interval of 10 years. BMJ (2000) 2.73
Current use of bisphosphonates in oncology. International Bone and Cancer Study Group. J Clin Oncol (1998) 2.73
Interim report and recommendations of the World Health Organization Task-Force for Osteoporosis. Osteoporos Int (1999) 2.70
A global representation of vitamin D status in healthy populations. Arch Osteoporos (2012) 2.69
Osteoarthritis of the hip: an occupational disease in farmers. BMJ (1992) 2.69
The assessment of vertebral deformity: a method for use in population studies and clinical trials. Osteoporos Int (1993) 2.66
A critical appraisal of the "human tumor stem-cell assay". N Engl J Med (1983) 2.60
Health-related quality of life in postmenopausal women with low BMD with or without prevalent vertebral fractures. J Bone Miner Res (2000) 2.55
A comparison between midline and mediolateral episiotomies. Br J Obstet Gynaecol (1980) 2.55
GLD-1, a cytoplasmic protein essential for oocyte differentiation, shows stage- and sex-specific expression during Caenorhabditis elegans germline development. Dev Biol (1996) 2.55
Occupational physical activities and osteoarthritis of the knee. Arthritis Rheum (2000) 2.54
Assessing the work of medical audit advisory groups in promoting audit in general practice. Qual Health Care (1995) 2.50
Double-blind controlled trial of oral clodronate in patients with bone metastases from breast cancer. J Clin Oncol (1993) 2.50
Manual handling activities and risk of low back pain in nurses. Occup Environ Med (1995) 2.48
Impact of nutrition on muscle mass, strength, and performance in older adults. Osteoporos Int (2012) 2.48
Use of statins and risk of fractures. JAMA (2001) 2.47
Prospective cohort study of predictors of incident low back pain in nurses. BMJ (1997) 2.46
X-ray diffraction study of the polymorphism of hydrated diacyl- and dialkylphosphatidylethanolamines. Biochemistry (1984) 2.45
Different membrane anchoring positions of tryptophan and lysine in synthetic transmembrane alpha-helical peptides. J Biol Chem (1999) 2.44
Interpretation and use of FRAX in clinical practice. Osteoporos Int (2011) 2.43
A UK Consensus Group on management of glucocorticoid-induced osteoporosis: an update. J Intern Med (1998) 2.42
Recommendations for standardization and phenotype definitions in genetic studies of osteoarthritis: the TREAT-OA consortium. Osteoarthritis Cartilage (2010) 2.39
Bone-density measurement. Lancet (1992) 2.38
Trends in admissions for hip fracture in England and Wales, 1968-85. BMJ (1990) 2.35
Anxiety disorders in cancer patients: their nature, associations, and relation to quality of life. J Clin Oncol (2002) 2.34
Population genetics of ice age brown bears. Proc Natl Acad Sci U S A (2000) 2.33
Calorimetric studies of the gel-fluid (L beta-L alpha) and lamellar-inverted hexagonal (L alpha-HII) phase transitions in dialkyl- and diacylphosphatidylethanolamines. Biochemistry (1983) 2.33